| Literature DB >> 30595911 |
GuangMing Zhou1, Xin Ju1, Bo Yu1, YunHai Tu1, JieLiang Shi1, EnDe Wu1, WenCan Wu1.
Abstract
PURPOSE: To evaluate the efficacy, feasibility, and safety of the navigation-guided endoscopy combined with deep lateral orbitotomy for removal of small tumors at the lateral orbital apex.Entities:
Year: 2018 PMID: 30595911 PMCID: PMC6286765 DOI: 10.1155/2018/2827491
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1Surgical view of removal of the tumor at the lateral orbital apex with a navigation-guided endoscope. (a) Matching the patient's anatomical landmark with imaging date. (b) Lateral orbitotomy removed the lateral wall. (c, d) Removing the lateral wall to expose the apex and access the tumor (white arrow) under a navigation-guided endoscope. (e, f) Intraconal tumor was identified and exposed fully (white arrow). (g) The tumor was removed integrally by cryoextraction. (h) Intact tumor size: 13 ∗ 8 mm.
Figure 2Computed tomography (CT) and magnetic resonance imaging (MRI) of the patient with schwannoma at the apex. (a, b) Orbital CT images showed a suborbicular and well-defined mass with isodensity mass located at the right inferolateral apex. (c) MRI T1-weighted images showed an isointensity mass at the right apex. (d) MRI T2-weighted images showed a high-intensity mass (white arrows).
Clinical date of 10 patients with tumors at the lateral orbital apex.
| Number | Sex | Age (years) | History (months) | BCVA | RAPD | Optic disc | Visual field | Tumor size (mm) | Tumor type | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | ||||||
| 01 | F | 26 | 6 | 6/300 | 6/7.5 | + | + | Pale | Pale | Irregular defect | Improved | 10 ∗ 12 | Cavernous hemangioma |
| 02 | F | 24 | 12 | 6/300 | 6/120 | + | + | Pale | Pale | Irregular defect | Improved | 10 ∗ 15 | Cavernous hemangioma |
| 03 | F | 61 | 60 | 6/300 | 6/7.5 | + | + | Normal | Normal | Irregular defect | Improved | 20 ∗ 15 | Cavernous hemangioma |
| 04 | F | 70 | 24 | 6/30 | 6/30 | − | − | Normal | Normal | Irregular defect | Improved | 18 ∗ 18 | Cavernous hemangioma |
| 05 | F | 68 | 3 | 6/6 | 6/6 | − | − | Normal | Normal | Irregular defect | Improved | 20 ∗ 10 | Cavernous hemangioma |
| 06 | M | 42 | 6 | 6/7.5 | 6/7.5 | − | − | Normal | Normal | Irregular defect | Improved | 10 ∗ 10 | Cavernous hemangioma |
| 07 | F | 32 | 12 | 6/10 | 6/6 | + | + | Pale | Pale | Irregular defect | Improved | 10 ∗ 15 | Cavernous hemangioma |
| 08 | F | 50 | 1 | 6/12 | 6/10 | + | + | Pale | Pale | Irregular defect | Improved | 12 ∗ 10 | Cavernous hemangioma |
| 09 | M | 47 | 24 | 6/7.5 | 6/7.5 | − | − | Normal | Normal | Irregular defect | Improved | 13 ∗ 8 | Schwannoma |
| 10 | F | 23 | 24 | 6/40 | 6/40 | − | − | Normal | Normal | Irregular defect | Improved | 20 ∗ 15 | Schwannoma |
BCVA: best corrected visual acuity; pre: preoperative; post: postoperative; RAPD: relative afferent pupillary dysfunction.